GAP1 Xenograft Project and the GAP1 Unique TMAs Project

Movember's Global Action Plan (GAP) prostate cancer biomarker initiative

Movember has released a global “Expression of Interest” to identify and engage interested researchers with relevant expertise in these two research areas:

The information received during the EOI process will be used to create trans-national multi-disciplinary teams who will collaborate to answer key clinical questions.